These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 22286071

  • 1. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
    Kisner T, Burst V, Teschner S, Benzing T, Kurschat CE.
    Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
    [Abstract] [Full Text] [Related]

  • 2. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M, Ampuero J, Anaya F.
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [Abstract] [Full Text] [Related]

  • 3. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
    Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A.
    Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
    [Abstract] [Full Text] [Related]

  • 4. Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab.
    Marasà M, Cravedi P, Ruggiero B, Ruggenenti P.
    BMJ Case Rep; 2014 Aug 25; 2014():. PubMed ID: 25155494
    [Abstract] [Full Text] [Related]

  • 5. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
    Hansrivijit P, Cheungpasitporn W, Thongprayoon C, Ghahramani N.
    BMC Nephrol; 2020 Apr 15; 21(1):134. PubMed ID: 32293308
    [Abstract] [Full Text] [Related]

  • 6. Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.
    Kronbichler A, König P, Busch M, Wolf G, Mayer G, Rudnicki M.
    Wien Klin Wochenschr; 2013 Jun 15; 125(11-12):328-33. PubMed ID: 23624956
    [Abstract] [Full Text] [Related]

  • 7. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP, van de Kar NC, Wetzels JF.
    Neth J Med; 2008 Nov 15; 66(10):408-15. PubMed ID: 19011266
    [Abstract] [Full Text] [Related]

  • 8. Rituximab in treatment of idiopathic glomerulopathy.
    El-Reshaid K, Sallam HT, Hakim AA, Al-Attiyah R.
    Saudi J Kidney Dis Transpl; 2012 Sep 15; 23(5):973-8. PubMed ID: 22982909
    [Abstract] [Full Text] [Related]

  • 9. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
    Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber L, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, Dötsch J.
    Nephrol Dial Transplant; 2012 May 15; 27(5):1910-5. PubMed ID: 22076431
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
    Clin Nephrol; 1995 Jun 15; 43(6):375-81. PubMed ID: 7554521
    [Abstract] [Full Text] [Related]

  • 11. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L.
    Transplantation; 2009 Aug 15; 88(3):417-20. PubMed ID: 19667947
    [Abstract] [Full Text] [Related]

  • 12. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA.
    Transpl Int; 2007 Jun 15; 20(6):558-62. PubMed ID: 17433091
    [Abstract] [Full Text] [Related]

  • 13. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS, Canetta PA, Beck LH, Ayalon R, Radhakrishnan J, Appel GB.
    Am J Nephrol; 2012 Jun 15; 36(1):58-67. PubMed ID: 22722778
    [Abstract] [Full Text] [Related]

  • 14. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
    Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, Conti G, Buemi M, Santoro D.
    Expert Opin Investig Drugs; 2018 Nov 15; 27(11):839-879. PubMed ID: 30360670
    [Abstract] [Full Text] [Related]

  • 15. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 15; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study.
    Lan L, Lin Y, Yu B, Wang Y, Pan H, Wang H, Lou X, Lang X, Zhang Q, Jin L, Yang Y, Xiao L, Chen J, Han F.
    Am J Nephrol; 2024 Nov 15; 55(1):25-36. PubMed ID: 37963441
    [Abstract] [Full Text] [Related]

  • 17. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
    Kolonko A, Piecha G, Więcek A.
    Transplant Proc; 2016 Nov 15; 48(9):3092-3094. PubMed ID: 27932154
    [Abstract] [Full Text] [Related]

  • 18. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
    Duncan N, Dhaygude A, Owen J, Cairns TD, Griffith M, McLean AG, Palmer A, Taube D.
    Nephrol Dial Transplant; 2004 Dec 15; 19(12):3062-7. PubMed ID: 15507477
    [Abstract] [Full Text] [Related]

  • 19. Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation - case report.
    Grenda R, Jarmużek W, Piątosa B, Rubik J.
    Pediatr Transplant; 2011 Sep 15; 15(6):E121-5. PubMed ID: 20331516
    [Abstract] [Full Text] [Related]

  • 20. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Radin M, Barreca A, Fenoglio R, Baldovino S, Menegatti E.
    Am J Nephrol; 2017 Sep 15; 46(2):108-113. PubMed ID: 28700988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.